These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 22967101)

  • 1. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
    Fransvea E; Trerotoli P; Sacco R; Bernabucci V; Milella M; Napoli N; Mazzocca A; Renna E; Quaranta M; Angarano G; Villa E; Antonaci S; Giannelli G
    J Viral Hepat; 2012 Oct; 19(10):704-10. PubMed ID: 22967101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients.
    Giannini EG; Basso M; Bazzica M; Contini P; Marenco S; Savarino V; Picciotto A
    J Viral Hepat; 2010 Aug; 17(8):563-8. PubMed ID: 19840364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.
    Miyasaka A; Kumagai I; Abe K; Suzuki K
    Hepatogastroenterology; 2012 May; 59(115):794-9. PubMed ID: 22020909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
    Giannini EG; Basso M; Savarino V; Picciotto A
    Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy.
    Köberle V; Waidmann O; Kronenberger B; Andrei A; Susser S; Füller C; Perner D; Zeuzem S; Sarrazin C; Piiper A
    J Viral Hepat; 2013 Aug; 20(8):530-5. PubMed ID: 23808991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
    Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
    Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
    J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
    Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
    Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma antigen production in nasal inverted papilloma.
    Suzuki M; Deng Z; Hasegawa M; Uehara T; Kiyuna A; Maeda H
    Am J Rhinol Allergy; 2012; 26(5):365-70. PubMed ID: 23168150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
    Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis.
    Cagnin M; Biasiolo A; Martini A; Ruvoletto M; Quarta S; Fasolato S; Angeli P; Fassina G; Pontisso P
    Sci Rep; 2019 Dec; 9(1):20126. PubMed ID: 31882893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients.
    Gallotta A; Paneghetti L; Mrázová V; Bednárová A; Kružlicová D; Frecer V; Miertus S; Biasiolo A; Martini A; Pontisso P; Fassina G
    Int J Biol Markers; 2018 May; 33(2):231-236. PubMed ID: 29712495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum SCCA levels in patients suffering cancers or other diseases.
    Yang D; Wang J; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():165-175. PubMed ID: 30905447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity.
    Sun Z; Shi X; Wang Y; Zhao Y
    Dermatology; 2018; 234(3-4):120-126. PubMed ID: 29870999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay for quantifying squamous cell carcinoma antigen in serum.
    Erickson JA; Lu J; Smith JJ; Bornhorst JA; Grenache DG; Ashwood ER
    Clin Chem; 2010 Sep; 56(9):1496-9. PubMed ID: 20601447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors determining the outcome of treatment in chronic hepatitis C.
    Hadziyannis SJ
    Acta Gastroenterol Belg; 2000; 63(2):207-9. PubMed ID: 10925467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum squamous cell carcinoma antigen: a potential marker for benign vulval disease?
    Abukhalil I; Redman C; Strange R
    Clin Exp Obstet Gynecol; 1995; 22(4):265-7. PubMed ID: 8777777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA].
    Maruyama K; Aoki Y; Yamanaka M; Ono M; Hotta T; Kang D
    Rinsho Byori; 2016 Mar; 64(3):265-9. PubMed ID: 27363218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.